Promising results from Novavax Phase 3 vaccine trial
18 June, 2021Novavax's COVID-19 vaccine demonstrated 100% protection against moderate and severe disease, with 90.4% efficacy overall, in the PREVENT-19 Phase 3 trial.
How to avoid dangerous mistakes when responding to anaphylaxis
18 June, 2021World Allergy Week is seeking to raise awareness of allergies and anaphylaxis, with leading allergy organisations promoting important resources that could save lives.
Hope after hip fracture with new registry toolbox launch
17 June, 2021The Hip Fracture Registry Toolbox is a practical and informative resource that explains the need, and how to best advocate, for the establishment of a national hip fracture registry.
New shingles vaccine now available in Australia
10 June, 2021GSK Australia has announced that a new vaccine to help protect against shingles in adults aged 50 years and older is now available on the private market in Australia.
Medical volunteers — Street Side Medical Clinic needs you!
03 June, 2021The mobile medical clinic providing health care to the homeless community in NSW is calling on doctors, nurses, physios and other medical volunteers.
National clinical guidelines released for endometriosis
02 June, 2021National clinical practice guidelines to diagnose and treat endometriosis have been released, aiming to improve the lives of women living with the debilitating condition.
Personal defibrillator gains CE certification
01 June, 2021Sydney-based medical device start-up RRR has secured European regulatory approval for its personal automated external defibrillator (AED), CellAED.
Metabolic hormone leptin linked to vaccine response
31 May, 2021 by Amy SarcevicReduced levels of the metabolic hormone leptin may be responsible for poor vaccine efficacy among certain individuals, according to a new study.
PBS-listed progesterone pessary slashes preterm birth risk
31 May, 2021A vaginal progesterone pessary is reported to be the first progesterone treatment to be reimbursed via the PBS for the prevention of preterm birth.
Infant pain-monitoring device gains international approval
28 May, 2021The smartphone-based pain assessment application has potential for use in children's hospitals, in postnatal wards, and among parents and other healthcare professionals.
Rising temperatures could lead to more stillbirths, study finds
28 May, 2021Early research suggests that climate change could lead to more stillbirths.
Last chance for aged-care providers to claim free PainChek licence
20 May, 2021This fortnight is the last chance for aged-care facilities to participate in the government-subsidised rollout of a complete point-of-care solution for best practice pain management.
New COVID-19 vaccine completely blocks viral transmission
19 May, 2021 by Amy SarcevicAn Adelaide-based company has developed a COVID-19 vaccine that completely blocks viral transmission to individuals who lack immunity, as well as offering protection for those inoculated.
Tech restores lives of those in chronic pain
19 May, 2021The Avalon Study has demonstrated the life-changing benefits of a closed-loop spinal cord stimulation system in patients with chronic, intractable pain.
COVID-19 antiviral treatment developed in Qld
18 May, 2021Australian and US researchers have developed an experimental direct-acting antiviral therapy to treat COVID-19.
